» Articles » PMID: 10888665

Differential Role of Beta(1C) and Beta(1A) Integrin Cytoplasmic Variants in Modulating Focal Adhesion Kinase, Protein Kinase B/AKT, and Ras/Mitogen-activated Protein Kinase Pathways

Overview
Journal Mol Biol Cell
Date 2000 Jul 11
PMID 10888665
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The integrin cytoplasmic domain modulates cell proliferation, adhesion, migration, and intracellular signaling. The beta(1) integrin subunits, beta(1C) and beta(1A), that contain variant cytoplasmic domains differentially affect cell proliferation; beta(1C) inhibits proliferation, whereas beta(1A) promotes it. We investigated the ability of beta(1C) and beta(1A) to modulate integrin-mediated signaling events that affect cell proliferation and survival in Chinese hamster ovary stable cell lines expressing either human beta(1C) or human beta(1A). The different cytodomains of either beta(1C) or beta(1A) did not affect either association with the endogenous alpha(2), alpha(V), and alpha(5) subunits or cell adhesion to fibronectin or TS2/16, a mAb to human beta(1). Upon engagement of endogenous and exogenous integrins by fibronectin, cells expressing beta(1C) showed significantly inhibited extracellular signal-regulated kinase (ERK) 2 activation compared with beta(1A) stable cell lines. In contrast, focal adhesion kinase phosphorylation and Protein Kinase B/AKT activity were not affected. Selective engagement of the exogenously expressed beta(1C) by TS2/16 led to stimulation of Protein Kinase B/AKT phosphorylation but not of ERK2 activation; in contrast, beta(1A) engagement induced activation of both proteins. We show that Ras activation was strongly reduced in beta(1C) stable cell lines in response to fibronectin adhesion and that expression of constitutively active Ras, Ras 61 (L), rescued beta(1C)-mediated down-regulation of ERK2 activation. Inhibition of cell proliferation in beta(1C) stable cell lines was attributable to an inhibitory effect of beta(1C) on the Ras/MAP kinase pathway because expression of activated MAPK kinase rescued beta(1C) antiproliferative effect. These findings show that the beta(1C) variant, by means of a unique signaling mechanism, selectively inhibits the MAP kinase pathway by preventing Ras activation without affecting either survival signals stimulated by integrins or cellular interactions with the extracellular matrix. These findings highlight a role for beta(1)-specific cytodomain sequences in maintaining an intracellular balance of proliferation and survival signals.

Citing Articles

CD29 is highly expressed on epithelial, myoepithelial, and mesenchymal stromal cells of human salivary glands.

Togarrati P, Dinglasan N, Desai S, Ryan W, Muench M Oral Dis. 2017; 24(4):561-572.

PMID: 29197149 PMC: 5902634. DOI: 10.1111/odi.12812.


Fyn/heterogeneous nuclear ribonucleoprotein E1 signaling regulates pancreatic cancer metastasis by affecting the alternative splicing of integrin β1.

Jiang P, Li Z, Tian F, Li X, Yang J Int J Oncol. 2017; 51(1):169-183.

PMID: 28560430 PMC: 5467783. DOI: 10.3892/ijo.2017.4018.


A novel intracellular fibulin-1D variant binds to the cytoplasmic domain of integrin beta 1 subunit.

Twal W, Hammad S, Guffy S, Argraves W Matrix Biol. 2015; 43:97-108.

PMID: 25661773 PMC: 4446149. DOI: 10.1016/j.matbio.2015.01.021.


Cell adhesion to fibronectin down-regulates the expression of Spy1 and contributes to drug resistance in multiple myeloma cells.

Fei M, Hang Q, Hou S, Ruan C Int J Hematol. 2013; 98(4):446-55.

PMID: 24037419 DOI: 10.1007/s12185-013-1435-4.


Beta1 integrins mediate cell proliferation in three-dimensional cultures by regulating expression of the sonic hedgehog effector protein, GLI1.

Goel H, Underwood J, Nickerson J, Hsieh C, Languino L J Cell Physiol. 2010; 224(1):210-7.

PMID: 20333644 PMC: 2885855. DOI: 10.1002/jcp.22116.


References
1.
Wary K, Mariotti A, Zurzolo C, Giancotti F . A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell. 1998; 94(5):625-34. DOI: 10.1016/s0092-8674(00)81604-9. View

2.
Meredith Jr J, Kiosses W, Takada Y, Schwartz M . Mutational analysis of cell cycle inhibition by integrin beta1C. J Biol Chem. 1999; 274(12):8111-6. DOI: 10.1074/jbc.274.12.8111. View

3.
Fornaro M, Tallini G, Zheng D, Flanagan W, Manzotti M, Languino L . p27(kip1) acts as a downstream effector of and is coexpressed with the beta1C integrin in prostatic adenocarcinoma. J Clin Invest. 1999; 103(3):321-9. PMC: 407898. DOI: 10.1172/JCI4585. View

4.
Lewis J, Schwartz M . Mapping in vivo associations of cytoplasmic proteins with integrin beta 1 cytoplasmic domain mutants. Mol Biol Cell. 1995; 6(2):151-60. PMC: 275825. DOI: 10.1091/mbc.6.2.151. View

5.
Yamakita Y, Totsukawa G, Yamashiro S, Fry D, Zhang X, Hanks S . Dissociation of FAK/p130(CAS)/c-Src complex during mitosis: role of mitosis-specific serine phosphorylation of FAK. J Cell Biol. 1999; 144(2):315-24. PMC: 2132894. DOI: 10.1083/jcb.144.2.315. View